• Profile
Close

microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome

Rheumatology Jun 10, 2018

van den Hoogen LL, et al. - Experts gauge the miRNA expression in relation to transcriptomic changes in plasmacytoid dendritic cells (pDCs) in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS). In SLE and APS, the major producers of IFNα are pDCs. For pDC activation, miRNAs are emerging regulators. In pDCs, lower miRNA expression is shared between SLE, SLE + APS and PAPS and it is associated to the IFN signature. Unique pathways for therapeutic intervention can be opened by a better understanding of the molecular mechanisms/pathways leading to pDC dysregulation in SLE and APS, as in these patients, pDCs are allegedly believed to be a source of the IFN signature.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay